Adial Pharmaceuticals, Inc. Preferred Stock, Shares Outstanding
Adial Pharmaceuticals, Inc. (ADIL) had Preferred Stock, Shares Outstanding of 0 shares as of 2026-03-31, per its 10-Q filed 2026-05-08.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockSharesOutstanding · last filed 2026-05-08
- 2026-03-31: Preferred Stock, Shares Outstanding 0.00 shares.
- 2025-12-31: Preferred Stock, Shares Outstanding 0.00 shares.
- 2025-09-30: Preferred Stock, Shares Outstanding 0.00 shares.
- 2025-06-30: Preferred Stock, Shares Outstanding 0.00 shares.
| Period end | Preferred Stock, Shares Outstanding |
|---|---|
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-08 |
| 2025-12-31 | 0.00 shares 10-Q · filed 2026-05-08 |
| 2025-09-30 | 0.00 shares 10-Q · filed 2025-11-13 |
| 2025-06-30 | 0.00 shares 10-Q · filed 2025-08-13 |
| 2025-03-31 | 0.00 shares 10-Q · filed 2025-05-14 |
| 2024-12-31 | 0.00 shares 10-K · filed 2026-03-05 |
| 2024-09-30 | 0.00 shares 10-Q · filed 2024-11-13 |
| 2024-06-30 | 0.00 shares 10-Q · filed 2024-08-13 |
| 2023-12-31 | 0.00 shares 10-K · filed 2025-03-04 |
| 2023-09-30 | 0.00 shares 10-Q · filed 2023-11-14 |
| 2023-06-30 | 0.00 shares 10-Q/A · filed 2023-10-30 |
| 2023-03-31 | 0.00 shares 10-Q · filed 2023-05-12 |
| 2022-12-31 | 0.00 shares 10-K · filed 2024-04-01 |
| 2022-09-30 | 0.00 shares 10-Q · filed 2022-11-14 |
| 2022-06-30 | 0.00 shares 10-Q · filed 2022-08-15 |
| 2022-03-31 | 0.00 shares 10-Q · filed 2022-05-16 |
| 2021-12-31 | 0.00 shares 10-K · filed 2023-03-30 |
| 2021-09-30 | 0.00 shares 10-Q · filed 2021-11-15 |
| 2021-06-30 | 0.00 shares 10-Q · filed 2021-08-12 |
| 2021-03-31 | 0.00 shares 10-Q · filed 2021-05-17 |
| 2020-12-31 | 0.00 shares 10-K · filed 2022-03-28 |
| 2020-09-30 | 0.00 shares 10-Q · filed 2020-11-13 |
| 2020-06-30 | 0.00 shares 10-Q · filed 2020-08-13 |
| 2020-03-31 | 0.00 shares 10-Q · filed 2020-05-14 |
| 2019-12-31 | 0.00 shares 10-K · filed 2021-03-22 |
| 2019-09-30 | 0.00 shares 10-Q · filed 2019-11-14 |
| 2019-06-30 | 0.00 shares 10-Q · filed 2019-08-13 |
| 2019-03-31 | 0.00 shares 10-Q · filed 2019-05-13 |
| 2018-12-31 | 0.00 shares 10-K · filed 2020-03-20 |
| 2018-09-30 | 0.00 shares 10-Q · filed 2018-11-14 |
| 2018-06-30 | 0.00 shares 10-Q · filed 2018-09-10 |
| 2017-12-31 | 0.00 shares 10-K · filed 2019-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |